0.0116
-0.0012
(-9.37%)
As of 4:59:50 PM GMT+1. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-9,212.0000
-5,254.0000
-4,003.0000
-1,540.0000
-211.7650
Investing Cash Flow
-2,502.0000
-4,961.0000
-5,272.0000
-1,375.0000
-315.3650
Financing Cash Flow
10,963.0000
4,599.0000
11,729.0000
3,867.0000
358.3350
End Cash Position
2,467.0000
1,055.0000
6,670.0000
4,216.0000
3,263.5070
Capital Expenditure
-2,502.0000
-4,961.0000
-5,272.0000
-1,375.0000
-315.3650
Issuance of Capital Stock
8,981.0000
4,599.0000
12,054.0000
--
--
Issuance of Debt
--
--
--
3,867.0000
358.3350
Free Cash Flow
-11,714.0000
-10,215.0000
-9,275.0000
-2,915.0000
-527.1300
12/31/2020 - 4/7/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MONI.ST Monivent AB
0.3180
+1.92%
CLS-B.ST Clinical Laserthermia Systems AB (publ)
3.2600
+4.49%
QLIFE.ST Qlife Holding AB (publ)
2.0000
-5.66%
QLINEA.ST Q-linea AB (publ)
0.4400
-12.00%
OSSD.ST OssDsign AB (publ)
11.60
+2.84%
XVIVO.ST Xvivo Perfusion AB (publ)
442.50
-6.94%
ACARIX.ST Acarix AB (publ)
0.2480
-0.60%
NAYA NAYA Biosciences, Inc.
0.4699
-6.02%
NUWE Nuwellis, Inc.
1.0450
-0.48%
NAOV NanoVibronix, Inc.
0.5245
+10.26%